-The Hindu 12-member team to go beyond present crisis, prepare road map for transparent budgeting with States The Supreme Court has constituted a 12-member National Task Force to streamline and ensure the “effective and transparent” allocation of liquid medical oxygen on a “scientific, rational and equitable basis” to States and Union Territories fighting COVID-19. The apex court had expressed its dissatisfaction at the Centre’s earlier “oxygen-for-bed” formula. This “rough-and-ready” arrangement, as the court...

-The Hindu She stresses on the protection that vaccines can offer against disease The current COVID-19 surge in India may begin to start tapering between the middle and end of May, virologist Gagandeep Kang said on Wednesday. At a virtual interaction with members of the Indian Women Press Corps, Dr. Kang said, “Best guess estimates from a number of models put this somewhere between the middle and end of the month. Some models...

-The Hindu Focus on severe ailments, combination of diseases excluding many: experts The Union Health Ministry’s list of 20 comorbidities that make people in the 45-59 year age group eligible for a COVID-19 vaccine is seen by some medical professionals as too narrow. “The list of comorbidities provided by the Health Ministry is overly restrictive and complicated. Many conditions, including obesity, have been left out,” said Dr. Gagandeep Kang, Professor of Microbiology at...

-The Hindu They advise against Covaxin, say there is no proof of efficacy. Several experts have raised concern over the “hasty approval” granted to the COVID-19 vaccines despite the lack of adequate efficacy data. The Central Drugs Standard Control Organisation on Sunday accorded approval for restricted emergency use of the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India (SII), and the indigenously developed vaccine Covaxin of Bharat Biotech. “I’m completely unaware...

-The Telegraph New Delhi: The Indian government will study 100,000 infants to evaluate a home-grown vaccine against rotavirus gastroenteritis, released this month amid concerns raised by a paediatrician about the risk of an intestinal side-effect. Doctors from Delhi, Pune and the Christian Medical College, Vellore, will measure -- through what could be India's largest study - any vaccine-associated risk of intussusception, a disorder in which the intestine telescopes into itself and may...